184 related articles for article (PubMed ID: 31964418)
1. Comprehensive molecular characterization of inhibitors of apoptosis proteins (IAPs) for therapeutic targeting in cancer.
Liang J; Zhao W; Tong P; Li P; Zhao Y; Li H; Liang J
BMC Med Genomics; 2020 Jan; 13(1):7. PubMed ID: 31964418
[TBL] [Abstract][Full Text] [Related]
2. A Pan-Cancer Analysis of the BIRC Gene Family and Its Association with Prognosis, Tumor Microenvironment, and Therapeutic Targets.
Wu S; Zang Q; Xing Z; Li X; Leng J; Liu Y; Wang X; Yang J
Crit Rev Eukaryot Gene Expr; 2021; 31(4):35-48. PubMed ID: 34587434
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies.
Smolewski P; Robak T
Curr Mol Med; 2011 Nov; 11(8):633-49. PubMed ID: 21902653
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of apoptotic proteins: new targets for anticancer therapy.
Saleem M; Qadir MI; Perveen N; Ahmad B; Saleem U; Irshad T; Ahmad B
Chem Biol Drug Des; 2013 Sep; 82(3):243-51. PubMed ID: 23790005
[TBL] [Abstract][Full Text] [Related]
5. Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs).
Rathore R; McCallum JE; Varghese E; Florea AM; Büsselberg D
Apoptosis; 2017 Jul; 22(7):898-919. PubMed ID: 28424988
[TBL] [Abstract][Full Text] [Related]
6. Targeting apoptosis pathways for new cancer therapeutics.
Bai L; Wang S
Annu Rev Med; 2014; 65():139-55. PubMed ID: 24188661
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Inhibitor of Apoptosis Protein Expression and Prognostic Significance in Non-Small Cell Lung Cancer.
Liu J; Lu Y; Huang W; He Z
Front Genet; 2021; 12():764270. PubMed ID: 34925455
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
[TBL] [Abstract][Full Text] [Related]
9. Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma.
Lederman M; Meir T; Zeschnigk M; Pe'er J; Chowers I
Curr Eye Res; 2008 Oct; 33(10):876-84. PubMed ID: 18853322
[TBL] [Abstract][Full Text] [Related]
10. The Opposite Effect of L-kynurenine and Ahr Inhibitor Ch223191 on Apoptotic Protein Expression in Pancreatic Carcinoma Cells (Panc-1).
Leja-Szpak A; Góralska M; Link-Lenczowski P; Czech U; Nawrot-Porąbka K; Bonior J; Jaworek J
Anticancer Agents Med Chem; 2019; 19(17):2079-2090. PubMed ID: 30987575
[TBL] [Abstract][Full Text] [Related]
11. Inhibitor of Apoptosis Proteins (IAPs) are commonly dysregulated in GIST and can be pharmacologically targeted to enhance the pro-apoptotic activity of imatinib.
Falkenhorst J; Grunewald S; Mühlenberg T; Marino-Enriquez A; Reis AC; Corless C; Heinrich M; Treckmann J; Podleska LE; Schuler M; Fletcher JA; Bauer S
Oncotarget; 2016 Jul; 7(27):41390-41403. PubMed ID: 27167336
[TBL] [Abstract][Full Text] [Related]
12. Targeting inhibitor of apoptosis proteins (IAPs) for cancer therapy.
Fulda S
Anticancer Agents Med Chem; 2008 Jun; 8(5):533-9. PubMed ID: 18537535
[TBL] [Abstract][Full Text] [Related]
13. Short-chain C6 ceramide sensitizes AT406-induced anti-pancreatic cancer cell activity.
Zhao X; Sun B; Zhang J; Zhang R; Zhang Q
Biochem Biophys Res Commun; 2016 Oct; 479(2):166-172. PubMed ID: 27562715
[TBL] [Abstract][Full Text] [Related]
14. Insect inhibitor-of-apoptosis (IAP) proteins are negatively regulated by signal-induced N-terminal degrons absent within viral IAP proteins.
Vandergaast R; Mitchell JK; Byers NM; Friesen PD
J Virol; 2015 Apr; 89(8):4481-93. PubMed ID: 25653450
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.
Hu T; Weng S; Tang W; Xue R; Chen S; Cai G; Cai Y; Shen X; Zhang S; Dong L
PLoS One; 2015; 10(5):e0125281. PubMed ID: 25933218
[TBL] [Abstract][Full Text] [Related]
16. Inhibitor of apoptosis proteins as targets for anticancer therapy.
Fulda S
Expert Rev Anticancer Ther; 2007 Sep; 7(9):1255-64. PubMed ID: 17892425
[TBL] [Abstract][Full Text] [Related]
17. The inhibitors of apoptosis (IAPs) and their emerging role in cancer.
LaCasse EC; Baird S; Korneluk RG; MacKenzie AE
Oncogene; 1998 Dec; 17(25):3247-59. PubMed ID: 9916987
[TBL] [Abstract][Full Text] [Related]
18. The inhibitors of apoptosis (IAPs) as cancer targets.
Hunter AM; LaCasse EC; Korneluk RG
Apoptosis; 2007 Sep; 12(9):1543-68. PubMed ID: 17573556
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of intracellular anti-apoptotic proteins, particularly c-FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL.
Hassanzadeh A; Farshdousti Hagh M; Alivand MR; Akbari AAM; Shams Asenjan K; Saraei R; Solali S
J Cell Physiol; 2018 Oct; 233(10):6470-6485. PubMed ID: 29741767
[TBL] [Abstract][Full Text] [Related]
20. The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer.
Nachmias B; Ashhab Y; Ben-Yehuda D
Semin Cancer Biol; 2004 Aug; 14(4):231-43. PubMed ID: 15219616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
